SACK1D and sarcoma: As shown in Figures 3A–L, the overall survival (OS) of patients with low expression of FAM83D was better than for patients with high expression of FAM83D in adrenocortical carcinoma (ACC; p < 0.001), bladder urothelial carcinoma (BLCA; p = 0.022), BRCA (p = 0.001), kidney chromophobe (KICH; p = 0.002), KIRP (p < 0.001), brain lower grade glioma (LGG; p < 0.001), LIHC (p < 0.001), LUAD (p < 0.001), mesothelioma (MESO; p < 0.001), PAAD (p < 0.001), sarcoma (SARC; p = 0.023), skin cutaneous melanoma (SKCM; p = 0.004), and uveal melanoma (UVM; p = 0.036).